Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid ...

Spokane County is considering expanding its opioid response by $650,000 after one program recently saw a roughly 85% success ...

The opioid crisis has touched nearly every demographic in our society. One area that doesn’t get enough attention is the toll ...

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary care clinicians ...

Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...

Montana Attorney General Austin Knudsen announced Montana will receive over $16 million from a settlemtn with Purdue Pharma ...

The U.S. Drug Enforcement Agency (DEA) announced on Jan. 16, 2025, three new rules intended to implement patient protections and permanently ...

Rodman & Renshaw initiated coverage on shares of Indivior (NASDAQ: INDV) with a positive outlook, assigning a Buy rating and setting a price target of $16.00. The firm's analysts see Indivior as a ...

Denver Health, the state’s flagship safety net hospital, did just that Monday morning, holding a ribbon cutting and unveiling ...

Laredo Public Health and Texas Dean Sen. Judith Zaffirini back bills that legalize fentanyl test strips to combat drug-related deaths amid the opioid crisis.

A groundbreaking treatment for substance use disorder is changing lives by using neuro-stimulation, and it’s exclusively available in the Louisville area.